These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 38694257)

  • 1. Clathrin mediated endocytosis in Alzheimer's disease: cell type specific involvement in amyloid beta pathology.
    Jaye S; Sandau US; Saugstad JA
    Front Aging Neurosci; 2024; 16():1378576. PubMed ID: 38694257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clathrin mediated endocytosis scaffolding protein, Intersectin 1, changes in an isoform, brain region, and sex specific manner in Alzheimer's disease.
    Jaye S; Sandau US; McFarland TJ; Woltjer RL; Saugstad JA
    Front Neurosci; 2024; 18():1426180. PubMed ID: 38915309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing the expression of PICALM reduces endocytosis and the activity of β-secretase: implications for Alzheimer's disease.
    Thomas RS; Henson A; Gerrish A; Jones L; Williams J; Kidd EJ
    BMC Neurosci; 2016 Jul; 17(1):50. PubMed ID: 27430330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD14 and Toll-Like Receptor 4 Promote Fibrillar Aβ42 Uptake by Microglia Through A Clathrin-Mediated Pathway.
    Fujikura M; Iwahara N; Hisahara S; Kawamata J; Matsumura A; Yokokawa K; Saito T; Manabe T; Matsushita T; Suzuki S; Shimohama S
    J Alzheimers Dis; 2019; 68(1):323-337. PubMed ID: 30775984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocytosis and Transcytosis of Amyloid-β Peptides by Astrocytes: A Possible Mechanism for Amyloid-β Clearance in Alzheimer's Disease.
    Domínguez-Prieto M; Velasco A; Tabernero A; Medina JM
    J Alzheimers Dis; 2018; 65(4):1109-1124. PubMed ID: 30103329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
    Lantz MJ; Roberts AM; Delgado DD; Nichols RA
    J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.
    Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK
    Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
    Dehghani R; Rahmani F; Rezaei N
    Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation.
    Chen Y; Yu Y
    J Neuroinflammation; 2023 Jul; 20(1):165. PubMed ID: 37452321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial cells in Alzheimer's disease: From neuropathological changes to therapeutic implications.
    Uddin MS; Lim LW
    Ageing Res Rev; 2022 Jun; 78():101622. PubMed ID: 35427810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in the Modeling of Alzheimer's Disease.
    Sasaguri H; Hashimoto S; Watamura N; Sato K; Takamura R; Nagata K; Tsubuki S; Ohshima T; Yoshiki A; Sato K; Kumita W; Sasaki E; Kitazume S; Nilsson P; Winblad B; Saito T; Iwata N; Saido TC
    Front Neurosci; 2022; 16():807473. PubMed ID: 35431779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocytes and neuroinflammation in Alzheimer's disease.
    Phillips EC; Croft CL; Kurbatskaya K; O'Neill MJ; Hutton ML; Hanger DP; Garwood CJ; Noble W
    Biochem Soc Trans; 2014 Oct; 42(5):1321-5. PubMed ID: 25233410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer's Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis.
    Bowirrat A
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMO and Alzheimer's disease.
    Lee L; Sakurai M; Matsuzaki S; Arancio O; Fraser P
    Neuromolecular Med; 2013 Dec; 15(4):720-36. PubMed ID: 23979993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuronal-specific isoform of BIN1 regulates β-secretase cleavage of APP and Aβ generation in a RIN3-dependent manner.
    Bhattacharyya R; Teves CAF; Long A; Hofert M; Tanzi RE
    Sci Rep; 2022 Mar; 12(1):3486. PubMed ID: 35241726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.
    Liu CC; Hu J; Zhao N; Wang J; Wang N; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
    J Neurosci; 2017 Apr; 37(15):4023-4031. PubMed ID: 28275161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of clathrin-mediated endocytosis prevents amyloid β-induced axonal damage.
    Kuboyama T; Lee YA; Nishiko H; Tohda C
    Neurobiol Aging; 2015 May; 36(5):1808-19. PubMed ID: 25772059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Analysis of Biological Processes Reveals Gene Co-expression Modules Driving Pathway Dysregulation in Alzheimer's Disease.
    Adeoye T; Shah SI; Ullah G
    bioRxiv; 2024 Mar; ():. PubMed ID: 38559218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.